Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06032455 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effectiveness of Multisystemic Therapy for Adolescents From Families With Intellectual Disabilities

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion dates: Dec 2026 to Sep 2027
    • Secondary endpoints: details revised at 1 of 14 entries
    • Site contacts updated at 1 of 4 sites
    v7
  2. Minor Study Identification, Study Status, Oversightv6
  3. Minor Study sites: 3 to 4
    • Collaborators: 5 to 6
    v5
  4. Minor Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 1 of 14 entries
    • Site details revised at 1 of 3 sites
    • Study description shortened, about 3 words
    v4
  5. Minor Re-verified, no change to tracked fieldsv3
  6. Notable Trial status: Not Yet Recruiting to Recruiting
    • Site details revised at 3 of 3 sites
    v2
  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational study is to determine the effectiveness of a specialisation of multisystemic therapy (MST) for adolescents with severe behavioural problems from families with an intellectual disability (ID; MST-ID). To achieve this goal, a mixed method study design is used. To this end, a quantitative and a qualitatively primary research question are formulated: * Is MST-ID superior, when compared to standard MST, in reducing rule-breaking behaviour of adolescents (quantitative)? * What are the experiences of adolescents and/or parents receiving MST-ID treatment (qualitative)? Participants will be asked to complete two screeners (questionnaires delivered as a verbal interview) with a total duration of approximately 30 minutes. Other data will be collected through Routine Outcome Monitoring questionnaires that are part of standard MST procedures. To this end, five 'time points' have been identified: T0 (start of MST\[-ID\] treatment), T1 (end of MST\[-ID\] treatment), T2 (follow-up 6 month after MST\[-ID\] treatment), T3 (follow-up 12 month after MST\[-ID\] treatment), and T4 (follow-up 18 month after MST\[-ID\] treatment). The qualitative method used to gain insight into families' experiences is determined in consultation with the families. To assess the effectiveness of MST-ID, its treatment outcomes will be compared to standard MST treatment outcomes of families with ID.
Trial Details
NCT Number NCT06032455
Lead Sponsor De Viersprong
Collaborators: Stichting tot Steun, Koraal, Prisma, MST-Netherlands/Belgium, Radboud University Medical Center, Pactum
Conditions
(from sponsor)
Behavioural Problems
Related terms Intellectual Disability, Mental Disorders
Enrollment 470 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov